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anesthesiologists and perfusionists that have worked with large animal models (pigs) for several
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bypass (CPB).
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83. Abbreviations
Alb Albumin
BMI Body mass index
BV Blood volume
CABG Coronary artery bypass grafting
CI Indexed values of cardiac output
CO Carbon monoxide
C.O. Cardiac output
COP Colloid osmotic pressure
COPp Colloid osmotic pressure in plasma
COPi Colloid osmotic pressure in interstitial fluid
CPB Cardiopulmonary bypass
CVP Central venous pressure
EVLW Extravascular lung water
FER Fluid extravasation rate
FiO2 Inspiratory fraction of oxygen
GEDV Global end-diastolic volume
Hb Hemoglobin
HbCO Carboxyhemoglobin
HES Hydroxyethyl starch
HSD Hypertonic saline / dextran
HSH Hypertonic saline / Hydroxyethyl starch
I Index (CI = cardiac index; SVRI = indexed value of SVR, etc)
ICP Intracranial pressure
ICU                                        Intensive care unit
ITBV Intrathoracic blood volume
Jv Net capillary filtration
JL Lymph flow
Kfc Capillary filtration coefficient
kD                                          kilo Dalton
LVEF Left ventricle ejection fraction
MAP Mean arterial pressure
Mw                                         Molecular weight
NFB Net fluid balance
PCWP Pulmonary capillary wedge pressure
Pc Capillary hydrostatic pressure
PEEP Positive end-expiratory pressure
Pi Interstitial fluid hydrostatic pressure
PV Plasma volume
SVR Systemic vascular resistance
 Sigma = Capillary reflection coefficient
TTW Total tissue water content
TEG                                       Thromboelastography
VRBC  Red cell volume
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5. Introduction
5.1. Background
5.1.1. Start of cardiac surgery
Cardiac surgery has been regarded as one of the most important medical advances in the
twentieth century. Different extracorporeal circulation techniques were developed more than 50
years ago to facilate treatment of congenital cardiac anomalies.
The first surgical procedures on these patients were performed using hypothermia and
inflow occlusion (Moller et al. 2009). Hypothermia decreased tissue oxygen requirements
(Bigelow et al. 1954) providing organs protection against ischemic injury, and allowed the
surgeon to interrupt circulation for a short time. The procedures performed with this technique
were mainly repair of atrial septum defects that could be closed within a few minutes.
For longer procedures new techniques were needed. John Gibbon successfully used a
screen oxygenator he had developed in 1953 for closure of an atrial septal defect in a 19-year-old
woman. The use of this equipment in the next 5 patients was, however, unsuccessful and further
attempts were discontinued.
In 1954 Lillehei and co-workers developed a new technique for “cardio-pulmonary-
bypass” where a human donor was used for “cross circulation” (Figure 1).
Figure 1: Cross circulation technique; (Adapted from Moller et al. 2009 Ann Thorac Surg 88:
1044-46, reprint with permission from author)
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The donor, often a relative, served as the oxygenator, and a pump provided blood flow
between the patient and donor. During a 14-month period 45 children were operated by use of
this technique and 28 patients were successfully repaired and discharged from the hospital. A
surgical mortality of 38 % would hardly have been accepted today, but it is important to
remember that most patients with congenital heart disease had a poor prognosis, often leading to
early fatality, before the development of the heart-lung machine.
In a 53-year follow-up study, 20 of the patients operated by use of the “cross circulation
technique” were still alive and had no limitations related to the previous cardiac operation they
had gone through (Moller et al. 2009).
The “cross-circulation technique” had limitations and was a risky procedure both for the
patient and the donor, and the search for more suitable strategies continued.
In 1955 the DeWall bubble oxygenator, that was developed in co-operation with Lillehei
and his group, was used for the first time (DeWall 2003). A 13-year-old boy with a ventricular
septal defect was the first patient. The system worked well, was widely accepted and was used
with an increasing frequency for open-heart surgery. The technology was, however, complex and
therefore slow to develop.
Throughout the years the equipment used in a typical extracorporeal circuit has advanced
considerably. Although the different circuits used today vary considerably between hospitals, the
basic concepts of extracorporeal circulation are essentially common to all CPB circuits in use.
5.1.2. The heart-lung machine and priming solutions
The standard equipment used in a heart-lung machine at present includes the main
elements of pump, oxygenator, venous reservoir, tubings, gas supply systems, different filters,
bubble traps as well as suckers and venting systems. In addition cardioplegia delivery systems
and in-line monitoring equipment are available together with a number of alarm systems.
Before use the machine has to be primed with a fluid solution, so that adequate flow rates
can rapidly be achieved upon initiation of cardiopulmonary bypass without any risk of air
embolism. Lactated or acetated Ringer’s solution is at present used as the main prime
component. This solution is capable, when mixed with the patient’s blood, to maintain oxygen
delivery and carbon dioxide removal and physiological homeostasis during extracorporeal
circulation. Although agreements on the use of non-blood prime, the final composition of the
priming solution is continuously under discussion.
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5.1.3. Cardiac surgery – at present
A great challenge in cardiac surgery is the change in patient population during the last
decades. Older age, more comorbidity, emergency surgery and female gender are all contributing
to increased risk during cardiac surgery (Kurki et al. 2003; Higgins 1998). Still, an increasing
number of high-risk patients are admitted to advanced surgery (Scrutinio & Giannuzzi 2008).
          To maintain low morbidity and mortality in this population it is important to optimize all
parts of their treatment. Small improvements may be the decisive factor when handling high-risk
patients.
         Fluid therapy in cardiac surgery offers challenges beyond other surgical specialities. The
patients` underlying cardiac disease, the complexity of the surgical intervention (including
cardiac arrest and hypothermia) and the pathophysiological impact of extracorporal circulation,
all contribute to the need for critical reflection when instituting fluid treatment protocols.
5.2. Fluid shifts
Starling`s observations (Starling 1896), which led to Starling equation, illustrates how the fluid
filtration through capillary membranes is dependent on the balance between the hydrostatic
pressure and the osmotic pressure of the membranes.
Figure 2:
Jv (Net capillary filtration) = Kfc [( Pc –Pi ) – (COPp – COPi)]
Venous
end
Lymphatic flow
Pi interstitial
Arterial
end
COPp intravascularPc intravascular
Blood
vessel
Hydrostatic Oncotic
COPi interstitial
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Kfc capillary filtration coefficient (a product of surface area and hydraulic conductance)
Pc capillary hydrostatic pressure
Pi interstitial fluid hydrostatic pressure
COPp intravascular oncotic pressure (COP in plasma)
COPi interstitial oncotic pressure (COP in interstitium)
 reflection coefficient (related to imperfect semipermeability, for plasma proteins
            usually 0.80-0.95)
Edema is an excess of interstital fluid, and is a result of:
Net Capillary Filtration > Lymphatic drainage rate
and may be caused by
• elevated capillary pressure (e.g. heart failure, over-transfusion, deep venous thrombosis)
• reduced plasma COP (e.g. malnutrition, malabsorption (lack of proteins) or hemodilution)
• reduced reflection coefficient (inflammation)
5.3. Additives
5.3.1. Colloides
Starlings discovery led to the use of solutions of artificial colloids to replace lost plasma
in wounded soldiers already during World War I. Development of a safe and inexpensive colloid
solution has been an ongoing process since. A selection of available products today is:
5.3.1.1. Albumin
            Albumin is derived from human plasma. Due to ethanol and heat treatment viral
transmissions are unlikely. 60 % of total protein present in plasma is albumin. There is a constant
movement of albumin between intra- and extravascular compartments.
           Human albumin has few adverse effects and is considered to be the colloid with least
influence on the coagulation. Still albumin may inhibit platelet aggregation and influence
bleeding (Vincent 2009). Interference with blood typing and allergic reactions is possible
(0.003 %), though less frequent compared to other colloides (Ring & Messmer 1977). Albumin
is a transport molecule, which should be kept in mind when treating patients exposed to multi-
pharmacia. Compared to other colloides it is expensive.
Available solutions are:
4 % (40 mg/ml) Albumin used in study I
20 % (200 mg/ml) Albumin
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5.3.1.2. Hydroxyethylstarch (HES)
              HES is frequently used as a plasma substitute, and is a modified natural polymer of
amylopectin (polysaccharide) found in plants such as potato and corn. A variety of different HES
solutions exist, and it is important to distinguish between the different preparations because of
the effect of plasma volume expansion as well as their effects on coagulation and other clinical
variables. Consentration, its molecular weight, its molar substitution, and the C2/C6 ratio define
HES solutions` physical and chemical characteristics. The molecules show great polydispersity,
and molecule size in the solutions follows a bell-shaped distribution, ranging from a few
thousand to a few millon daltons. The number and weight of molecules (70kD - 480kD)
determines colloidal activity.
                   The molar substitution expresses the average number of hydroxyethyl groups per
unit of glucose, and varies from 0.4-0.7, (how many hydroxyethyl groups exist/10 u of glucose).
The C2/C6 ratio describes more precisely the substitution pattern (the hydroxyethyl units are
most frequently at position C2 and C6) (Treib et al. 1999). High molar substitution and high
ratio indicates delay in breakdown and elimination of hydroxyethyl starch, resulting in a
relatively long-lasting effect, but also risk of accumulation of molecules, and subsequently a
higher risk of adverse effects. The first generations had a molecular weight of 400-600 kD, and
molar substitution of 0.7. There has been a continuous improvement of these solutions, with the
newest ones weighing only 130 kD, and with a molar substitution of 0.4.
                  HES might interfere with normal hemostasis at different levels. Large molecules can
interfere with fibrinogen, coagulation factor VIII, and the von Willebrand factor (Kozek-
Langenecker 2005). Anaphylactic reactions are, estimated to a frequency of 0.006%, lower than
for both dextran and gelantine (Ring & Messmer 1977). The frequency is slightly higher than for
albumin, even though some studies report similar values for albumin and HES (Laxenaire et al.
1994).
             There has been increasing interest concerning the effects of HES on renal function.
Impaired renal function has been described (Cittanova et al. 1996), as well as swelling of renal
tubular cells after administration of certain HES preparations (Boldt 2009a). A suggested
mechanism of renal dysfunction is the induction of hyperviscosity of the urine by infusion of
hyperoncotic colloids in dehydrated patients, and can be avoided by adequate hydration (Boldt
2009a).
Available solutions are:
HAES; (6% HES 200/05), used in study I
Voluven; (6% HES 130/04)
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5.3.1.3. Dextran
             Dextran is polysaccaride molecules of high molecular weight, synthesised from sucrose
from lactic-acid bacteria and with a molecular weight ranging from 40-70 kD. Dextrans may
induce abnormal bleeding due to their effects on primary hemostasis and on the fibrinolytic
system. Infusions may induce a “von Willebrand syndrome” with decreased levels of von
Willebrand factor and associated factor VIII (Van der Linden & Ickx 2006). Dextrans also
enhance fibrinolysis. They are more often than other colloides associated with anaphylactoid
reactions (Ring & Messmer 1977), and the use of dextran 1 (hapten inhibition) are usually
recomended to reduce the risk for DIAR (dextrane induced anafylactoid reactions).
Available solutions are:
Macrodex; (6 % dextran 70)
Plasmodex®; (6% dextran 30)
5.3.2. Hypertonic saline/colloidal solutions
          Hyperosmolar solutions intend to make use of the large interstitial and intracellular
reservoirs. The first study from Velasco (Velasco et al. 1980) and co-workers reported that a
small infusion of hypertonic saline (7.5 % NaCl) of only 10 % of shed blood volume rapidly
restored arterial pressure and cardiac output to baseline values.
             The use of hypertonic saline started as development of solutions for small-volume
resuscitation. Several beneficial effects were observed; increased cardiac output, fall in total
peripheral resistance and improved renal perfusion (Nakayama et al. 1984). Different
hyperosmolar solutions have been tested, like mannitol and glucose, and the increased osmolality
of all solutions produced rapid initial improvements. The response did not require sodium or
chloride. However, the decline in improvements was slowest with hypertonic saline (Kramer
2003).
              As these improvements were short-lived, combination fluids were developed. Several
studies observed improved results of hypertonic saline in combination with colloides, compared
with one of the solutions used alone (Kramer 2003; Holcroft et al. 1987; Smith et al. 1985).
          By maintaining the COP with colloides, fluid mobilized from the extravascular space by
the osmotic effect of hypertonic saline, remained for a longer period in the intravascular
compartment.
Available solutions are:
HyperHaes; (6% HES (200/05), 7,2 % NaCl) used in study II, IV and V
Rescueflow; (6 % dextran (70), 7,5 % NaCl) used in study III.
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5.3.3. Crystalloides
           Crystalloides are aqueous solutions of mineral salts or other water-soluble molecules and
are disseminated homogenously throughout the plasma volume and interstitium. Due to this fact,
a four-fold amount of fluids is needed in order to achieve the same intravasal volume effect as
whole blood or colloid plasma substitution (Schumacher and Klotz 2009). Most solutions are
balanced electrolyts solutions largely corresponding to plasma composition. Lactated or acetated
Ringer’s solutions are most commonly used. Lactated Ringer’s solution might exacerbate pre-
existing acidosis and interfer with lactate as a marker of hypoxia (Zander Rolf 2006). In Norway
actated Ringer’s solutions is most common.
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6.0 Aims of the study
Negative impact of fluid overload has gained increasing interest during the last years. Fluid
overloading with edema formation is a regular finding following on-pump cardiac surgery.
Hemodilution is one of the important contributors to this fluid loading.
The aim of the present study was to evaluate the effect of different colloidal additives on
fluid loading and edema generation during CPB in an experimental model, and to translate the
results into a clinical setting focusing on eventual consequences for organ function.
The specific aims of the different sub-projects were to investigate:
• Whether maintainance of COP by use of iso-oncotic prime could reduce fluid leakage
during CPB (Paper I)
• How a slow infusion of hypertonic saline/hydroxyethyl starch during CPB influenced
fluid shifts and edema generation in the different organs, brain included (Paper II)
• The effects of hypertonic saline/dextran infusion during CPB on fluid homeostasis
(Paper III)
• To what extent a given amount of hypertonic saline/hydroxyethyl administered as  prime
additive during CPB could influence fluid balance/distribution (Paper IV)
• Wheather a hypertonic saline/hydroxyethyl additive influenced fluid balance also during
tepid CPB (Paper IV)
• A: If the results of the experimental studies could be translated into clinical practice, and
B: How can a conceivable reduction in NFB by infusion of hypertonic
saline/hydroxyethyl starch to CABG patients during CPB impact cardiopulmonary
function in the early postoperative hours (Study V)
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7. Materials and methods
7.1 Experimental studies (paper I-IV)
7.1.1. Animals and animal handling
            Pigs are commonly used in cardiovascular research because they share important
anatomic and physiologic characteristics with humans. Their hearts are approximately of the
same size, and coronary blood flow, hemodynamics and myocardial contractility are analogous
(Becker et al. 1972; Swindle 1984; Hughes 1986). Compared to former use of dogs, they are
more suitable both from an anatomic and physiologic viewpoint. The availability and price is
also considerably lower (Swindle 1984). A piglet model (Norwegian landrace-Yorkshire hybrid)
is well established in our research lab, and has been used for studies on fluid shifts during CPB
for several years (Heltne 2002, Farstad 2006, Haugen 2008).
All experimental studies were carried out in pigs weighing 28-35 kg. Handling of the animals
and procedures described were approved and in accordance with recommendations given by
Norwegian Animal Research Authority. The animals were acclimatised in the laboratory animal
housing area for at least 3 days prior to the experiments. Water was available until pre-
medication was given, while food was withdrawn 8-12 hours before.
Anesthesia and surgery
            The piglets were anesthetized according to a standard protocol (Husby et al. 1998). 20
min prior to induction of anesthesia, ketamine 15 mg/kg, diazepam 0.3 mg/kg and atropine 1 mg
was given i.m. Inhalation of isoflurane 1-3 % in oxygen was used for induction of general
anesthesia. Additionally thiopenthone 5 mg/kg was given i.v. prior to tracheal  intubation and
start of mechanical ventilation. Isoflurane inhalation 0.5-1.5 % delivered in 50% oxygen in air
via a ventilator was used together with an infusion of midazolam 0.5 mg/kg/h and fentanyl 7.5
μg/kg/h to maintain anesthesia. In addition pancuronium 45 g/kg/h was given as an infusion in
paper II-IV to avoid shiverings during temperature reduction.
In paper II and III an ICP transducer and a microdialysis catheter was placed into brain
parenchyma through a burr hole as described in the respective papers.
               Mid-line sternotomy was performed along with cannulation of the aorta (18 Fr) and the
right atrium (35 Fr). The left ventricle was vented (17 Fr) via the apex. A 5 Fr pulmonary artery
catheter was introduced until wedging position was achived in the pulmonary artery (Edwards
Lifesciences, Irvine, Ca, USA).
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 Intravascular catheters were placed in the femoral artery for recording of MAP and
blood sampling, and in femoral vein for fluid substitution and CVP-measurements. Surgery was
normally completed within 30 min.
 In the end of the experiment, when fully anesthetized, the animals were euthanized with
an injection of potassium chloride.
Cardiopulmonary bypass
               Standard equipment for open-heart surgery (Quadrox, hollow fibre membrane
oxygenator with venous hardshell cardiotomy reservoir, VHK 4200, Jostra, AG, Hirrlingen,
Germany) was used. The machine reservoir was filled to a level of 300 ml (400 ml in paper I)
and maintained at that level during the bypass period. Initial prime volume was 1115 ml (1000ml
in paper I). Pump flow was set to 2.7 l/min/m2. Flow pattern was non-pulsatile. The CPB head
pressures were in the range of 200-250 mmHg. During CPB the height difference between the
machine reservoir and the right atrium was fixed (73 ± 3 cm). Left ventricle was vented by use of
a 17 Fr. vent catheter. Free venous drainage was ensured continuously by visual inspection and
by monitoring of the central venous pressure (CVP) in the right atrium.
7.1.2. Experimental protocol
Paper I
            Three groups were studied: CT-group (control group) where the CPB circuit was primed
with acetated Ringer`s solution, and when needed, acetated Ringer`s solution was added to the
reservoir. In the Alb-group the CPB circuit was primed with 4% albumin, and when needed,
albumin 4% was added to the reservoir. In the last group, HES-group, HES (200/05), was mixed
with acetated Ringer`s solution to obtain a COP equivalent to the in vivo plasma COP in each
animal, this mixture was also added to the reservoir when needed. In all groups the primimg
volum was 1000 ml, including 400 ml in the reservoir. After stabilization for 60 min,
normothermic CPB (38ºC-39ºC) was initiated and continued for 60 minutes followed by 90
minutes of hypothermic CPB (28ºC ).
Paper II
            In this study two groups of animals received a continuos infusion. In the CT-group
(control group) an infusion of acetated Ringer´s solution 5 ml/kg/hour was started immediately
after anesthesia, and continued until termination of CPB. In the HSH-group the infusion was 1
ml/kg/h of hypertonic saline/hetastarch (HyperHaes®) combined with 4 ml/kg/h of acetated
Ringer´s solution and was given in the same period. After stabilization for 60 min, normothermic
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CPB (38 ºC-39 ºC) was initiated and continued for 60 minutes followed by 90 minutes of
hypothermic CPB (28 ºC). In both groups the primimg volum was 1115 ml, including 300 ml in
the reservoir. Acetated Ringer´s solution was used when needed in the resvoir.
Paper III
                In this study exactly the same protocoll as in study II was used, with the exeception of
the study fluid. HSH was replaced with hypertonic saline/dextran (Rescueflow®).
Paper IV
              An addition in the prime was used in this study. In the interventional group (H-group),
 4 ml/kg hypertonic saline/hetastarch (HyperHaes®) replaced acetated Ringer´s solution in the
prime, whearas only acetated Ringer´s solution was used in the control group (C-group). After
stabilization for 60 min, CPB was initiated and continued for 120 min. During CPB the
temperature drifted to a ”tepid” level (33 ºC -35 ºC). In both groups the priming volume was
1115 ml, including 300 ml in the reservoir. Acetated Ringer´s solution was used when needed in
the reservoir.
7.1.3. Monitoring, measurements and calculations
Plasma and blood volume determination
           To calculate changes in plasma volum and fluid-shifts the exact volume of the blood need
to be determinated. Several tracers have been used. Carbonmonoxide has been used as tracer in
different studies during the last years, initially developed by Fogh-Andersen and co-workers
(Fogh-Andersen et al. 1987). The technique was further sophisticated by Burge and Skinner who
presented a detailed description of all calculations leading to hemoglobin (Hb) mass and blood
volume determination (Burge & Skinner 1995). Heltne and co-workers further developed the
technique for use in pigs (Heltne et al. 2002). 30ml of CO was administered into a closed circle
re-breathing system. The amount of Hb in the blood was calculated from the increase in HbCO
fraction after 10 min. The method was used in paper I-IV.
Baseline plasma volume was calculated from the following equations:
nCO = 1000 x [(PB/1013,33) x VCO/0,08206 x (273+T)]
nHb = (nCO x 25 )/COHb
VRBC = (644 x Hct x nHb) / Hb
BV = (VRBC x 100) / Hct x Fcell ratio
PV = BV - VRBC
nCO = number of mmol CO added to the breathing system
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PB = barometric pressure (kPa)
VCO = volume of CO added to the breathing system (litre)
T = room temperature (°C)
nHb = number of mmol hemoglobin in the animal
COHb = difference in HbCO before and after CO administration
VRBC = erythrocyte volume in the animal (millilitre)
Hct = hematocrit (%)
Hb = hemoglobin (gram per litre)
BV = blood volume in the animal (millilitre)
Fcell ratio = correction factor for trapped plasma (0.96 – 0.98)
PV = plasma volume in the animal (millilitre)
 PV = change in PV from one time intervall to the next
Blood losses were measured, and blood samples taken every 30 min. From the Hb and the
hematocrit values obtained, together with the blood loss, changes in plasma volume were
calculated;
New VRBC   = Previous VRBC   - blood loss x [(Hct start of period + Hct end of period): 2]
New PV      = (New VRBC   / Hct end of period) – New VRBC
During CPB the calculated total PV was corrected according to the volume in the heart-lung-
maschine.
NFB (Net Fluid Balance) is the total amount fluids added minus diuresis and bleeding
.
FER (Fluid Extravasation Rate) is NFB minus  PV
Both values measured as ml/kg/h unit and were calculated every 30 min.
Total tissue water content
             Immediately after the animals had been killed, samples were collected from the brain,
heart, lungs, intestinal organs, muscle and skin. The samples were placed in preweighed vials to
determine weight. Thereafter they were dried at 70 °C, and weighed repeatedly until stable
weight. The difference between first and last measurement is presented as total tissue water.
Colloid osmotic pressure (COP)
             Measurements of COP in interstitial fluid (COPi) and plasma (COPp) are well
established methods in our research group. The technique is based on the wick-method (Aukland
et al. 1975) and has been evaluated in pigs (Heltne et al. 1998). By keeping the nylon wicks,
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soaked in saline, in situ for 90-120 min before removal, the best correlation between obtained
values and true COPi (interstitial) was found. The wicks were centrifuged under mineral oil to
obtain undiluted wick fluid. Blood samples for measuring COPp were taken every 30-min and
centrifuged before analyzing. Fluids from both the interstitia and plasma were then measured
with a colloid osmometer using a semi-permeable membrane with a cut-off level at 30.000 (PM-
30 Amicon, Lexington, USA) with acetated Ringer`s solution in the reference chamber. Pressure
was measured by a pressure transducer (Gold-Statham, Spectramed, USA) connected to a
recorder (Easy-Graph 240.Gould Inc., USA).
This method was used in paper I-IV.
Cerebral monitoring
              Intracranial pressure (ICP) monitoring was included in study II-IV. In addition
microdialysis was included in study II to obtain markers of cerebral metabolism. The basic
principle of this technique is to mimic the function of a capillary blood vessel by perfusing a thin
dialysis catheter implanted into the tissue with a physiological solution (Ungerstedt 1991). The
analyzed perfusate reflects the composition of the extracellular fluid. The catheter was perfused
with CNS perfusion fluid (CMA) 0.3 l/min by a microinfusion pump (CMA 107). Samples
were collected every 30-min and analyzed with respect to glucose, glycerol, lactate and pyruvate
in a CMA 600 Microdialysis Analyzer (CMA Microdialysis AB, Stocholm, Sweden).
7.2. Clinical study (paper V)
49 patients scheduled for elective CABG were included in this double-blinded,
randomized clinical control trial. The study was approved by the Regional Committee for
Medical Research Ethics in Western Norway, the Norwegian Social Science Data Services, and
the Directorate for Health and Social Affairs and by the Norwegian Medicines Agency.
Anesthesia and surgery
The patients were anesthetized according to standard procedyre in our department, using
midazolam, fentanyl, thiopentone, pancuronium, and isoflurane in oxygen/air for maintainance
of general anesthesia. After induction of anesthesia a thermistor catheter (PVPK2015L20;
Pulsion Medical Systems AG, Munich, Germany) was placed in the right femoral artery, and the
transpulmonary thermodilution technique PiCCO®plus system was used for monitoring cardiac
output (C.O.), intrathoracic blood volume (ITBV), extravascular lung water (EVLW) and global
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end-diastolic volume (GEDV) at different time intervals. Only two surgeons performed the
surgery of the patients, using the same technique.
Cardiopulmonary bypass
              The CPB circuit consisted of roller pump, venous cardiotomy reservoir, arterial line
filter (Medtronic Affinity 38μ, Trillium Biopassive Surface), tubings and a hollowfiber
oxygenator (Affinity Trillium coating NT, Medtronic INC, Minneapolis, MN, USA). Flow
pattern was non-pulsatile and mean arterial pressure was maintained between 50 and 70 mmHg.
Standard cannulation in the ascending aorta (Medtronic 22 FR, DLP 89022) and the right atrium
(Medtronic Threestage, MC2X-91429-29 FR) were used. Acid-base parameters were regulated
according to the α-stat strategy. Tepid temperature ( 34 °C) was used in all patients.
Myocardial protection was performed with cold blood cardioplegia (modified St.Thomas
solution with blood, 10 °C), at 20-minute intervals.
Postoperative care
              Assisted ventilation was maintained until following standard criteria were fulfilled: the
patient was hemodynamic stable, thoracic drainage <50 ml/h, bladder temperature, >36.5°C.
Extubation was performed when the patient was awake, arterial pO2 > 9.5 kPa, pCO2 < 6.5 kPa
and tidal volume > 7 ml/kg during CPAP (Continuous Positive Airway Pressure)-ventilation.
Fluid supplementation and diuretics were used according to the physician on duty.
Study Protocol
          Patients were randomized to receive either a continuous infusion of HyperHAES® (HSH-
group), which consists of 60 mg/ml of poly (O-2-hydroxyethyl) starch (Hetastarch 200/05, 1232
mmol/l sodium, 1232 mmol/ml chloride, osmolality 2464 mosmol/l (Fresenius Kabi, Uppsala,
Sweden) or acetated Ringer’s solution (CT-group). Infusion started upon arrival in the operating
theatre just after preoperative hemodynamic baseline values were obtained (PiCCO®plus
system). Both groups received acetated Ringer’s solution 4 ml/kg/h and 1 ml/kg/h of the blinded
test solution throughout 4 hours. Accurate accounts of fluid additions, blood loss and diuresis
were kept.
Laboratory data
Acid-base samples were measured regulary. Blood samples of Hb, Evf, Tpk, serum-
sodium, serum-chloride, serum-glucose and serum-creatinine were measured pre-and
postoperatively and additionally at day 1, 2 and 3 after operation.
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Thrombelastography (TEG®)
               Thrombelastography (TEG®, Haemoscope Corpotation, Niles, IL, USA) was used for
evaluating blood coagulation, and shows the viscoelastic changes that occur during coagulation,
and enable an evaluation of the process of clot initiation, formation and stability. The TEG gives
a graphic representation of clot formation and subsequent lysis (Luddington 2005).
Figure 3.
I Thrombosis            Fibrinolysis   
TEG variables include:
r (reaction time), time to initial fibrin formation (Prolongation of r time may be a result of
coagulation factor defiencies, anticoagulation (heparin) or severe hypofibrinogenaemia. A
small r value may be present in hyper-coagulability syndroms.
k (clot formation time)
rk (r +k, or coagulation time)
	-angle (clot formation rate)
MA (maximum amplitude, cloth strength). Platelet abnormalities, both qualitative and
quantitative, disturb MA
CI (TEG coagulation index, which is derived from a linear equation that combines all the
TEG variables, and the normal range is + 2 to – 2.)
Blood was sampled after induction of anesthesia and 1 hour postoperatively, and analyzed.
Cytokines / Cytokine analysis
A panel of cytokines was quantified in plasma from samples collected at different time
points. A multiplex fluorescent bead immunoassay kit (Linco Research Inc, St. Charles, MI,
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USA) was used for the simultaneous quantification of the following cytokines: IL-6, IL-8,
 IL-10 and TNF-	. The samples were prepared for analysis by dilution with serum matrix diluent
and the analysis performed as specified by the manufacturer. Total surface fluorescence was
measured with a flow-based dual laser system (Luminex100, Luminex Corporation, Austin, TX,
USA). The concentration of cytokines was calculated with reference to a standard curve based on
a broad range of standards (4.8-20 000 pg/ml), providing the lower and upper detection level for
all the assayed cytokines.
Transpulmonary thermodilution tecnique PICCO®
           Determination of cardiac output (C.O.), intrathoracic blood volume (ITBV), extravascular
lung water (EVLW) and global end diastolic volume (GEDV) was monitored by use of the
transpulmonary thermodilution technique PiCCO®plus system (Pulsion Medical Systems AG,
Munich, Germany). The thermodilution technique is less invasive then pulmonary-artery (PA)-
catheters. It is a well tested, simple and accurate technique (Ganz et al. 1971). The PICCO
catheter consists of two parts; an arterial catheter and a temperature sensor (se fig.4). In addition
a CVK (central venous catheter) is needed to perform measurements and calculations. A bolus of
sodium chloride administered by a central venous injection passes through the cardiopulmonary
system. The temperature sensor at the tip of the PICCO-catheter, which measures continuous
invasive body temperature, captures then the thermodilution curve. From this thermodilution
curve, patients C.O., ITVB, EVLW, and GEDV are calculated. Indexed values are estimated
according to patient’s body surface.
Figure 4.
 (Printed with permission from PULSION Medical Systems AG)
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8. Synopsis of results
Paper I
(The Journal of Thoracic and Cardiovascular Surgery 2005 Aug; 130(2): 287-94)
This study aimed to compare iso-oncotic priming solutions to crystalloid priming
(acetated Ringer`s solution), with regard to fluid extravasation during cardiopulmonary bypass in
piglets. Three groups were compared. One group received only acetated Ringers`s solution as
prime, one group received 4 % albumin as prime and the last group received HES 200/0.5 mixed
with acetated Ringers`s solution as prime. The mixture was composed to obtain a COP
equivalent to the in vivo plasma COP present in each individual animal.
Upon initiation of hypothermia FER increased in the Ringer-group, whereas FER remained
stable in the two other groups. Preservation of COP reduced fluid extravasation during CPB.
Total tissue water increased in most organs when acetated Ringer`s solution was used. The use
of colloidal priming reduced the amount of tissue water in a number of organs. In this study
albumin turned out to be more effective than HES in reducing the cold-related fluid shifts.
Paper II
(Acta Anaesthesiologica Scandinavica 2006 Aug; 50(7): 855-62)
During 60 min normo- and 90 min hypo-thermic CPB, an infusion of 5 ml/kg/h of
acetated Ringer`s solution was given to the control animals (CT-group). In the interventional
group (HSH-group) 1ml/kg/h was replaced with hypertonic saline/ hydroxyethyl starch 200/0.5
(HSH).  This dose of HSH effectively reduced total fluid gain about 50 % during the CPB
period. During hypothermic CPB there was an increase in FER in both groups. FER increased in
the HSH-group, from 0.15 (0.08) to 0.33 (0.08) ml/kg/min and in CT-group from 0.19 (0.14) to
0.51 (0.10) ml/kg/min. FER of the HSH-group was significantly lower than FER of the CT-
group. Total tissue water content of the heart and the lungs was significantly lower in the HSH-
group compared to the CT-group. Administration of HSH infusion was associated with stable
ICP values wheras ICP of the CT-group increased significantly during bypass.
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Paper III
(Scandinavian Cardiovascular journal 2008 Feb; 42(1): 63-70)
In this study we used the same protocol as in study II. HSH was replaced by HSD
(hypertonic saline /dextran). HSD was given at a rate at 1ml/kg/h which resulted in a reduction
of total fluid gain by 60 % when compared to the CT-group which was given the same amount of
acetated Ringer’s solution. The study was performed in14 piglets, 7 in each group, during
normothermic followed by hypothermic CPB. During hypothermic CPB there was an increase in
FER in both groups. FER increased in the HSD-group, from 0.01 (0.04) to 0.17 (0.07) ml/kg/min
and in CT-group from 0.25 (0.23) to 0.57 (0.14) ml/kg/min. TTW was significantly lower in the
heart and some of the visceral organs in the HSD-group. ICP remained stable in HSD-group,
whereas a significant increase was observed in the CT-group. No adverse effects were observed.
Paper IV
(Perfusion 2008 Jan; 23(1): 57-63)
A protocol with “tepid” temperature during cardiopulmonary bypass was used in this
study. A solution of HSH, 4ml/kg, replaced the same amount of acetated Ringer’s solution in the
prime (H-group). In the control-group (C-group) the prime was only acetated Ringers`s solution.
The animals were allowed to drift to tepid temperature (35 °C). Total fluid needs during 120 min
CPB was reduced by 60% in H-group related to lowered values of fluid extravasation. The effect
was most pronounced during the first 30 min on CPB. FER increased from 0.13 (0.04) to 1.6
(0.4) ml/kg/min in C-group, compared with 0.17 (0.11) and 0.68 (0.42) ml/kg/min in H-group,
respectively. Hemodynamics and laboratory parameters were similar in both groups.
Paper V
(Acta Anaesthesiologica Scandinavica :2010 april; 54(4): 485-93)
          In this clinical double-blinded study we randomized 50 patients scheduled for elective
CABG surgery into two groups. In the interventional group an infusion of 1 ml/kg /h of HSH was
given during 4 hours. In the control group the same amount of acetate Ringers`s solution was
given. Hemodynamic parameters were obtained using the PICCO-system. All fluid additives and
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losses until next morning were registered. Net fluid balance (NFB) was 4 times higher in the
CT-group compared to the HSH-group during the first 6 hours postoperatively. Total fluid gain
until next morning was significantly lower in the HSH-group (2993.9 (938.6) ml) compared to the
CT-group (4298.7 (1059.3) ml) (P< 0.001). Normalized values (i.e. %-changes from baseline) of
cardiac index and global end diastolic volume index increased postoperatively in both groups.
Both parameters were significantly higher at 6 h in the HSH-group compared to CT-group.
Normalized values of intrathoracic blood volume index were lower in the HSH-group at 6 h
postoperatively when compared to CT-group. PaO2/FiO2 ratio decreased similarly in both groups
early postoperatively, but recovery tended to be more rapid and pronounced in the HSH-group.
Although serum-sodium and serum-chloride levels were significantly higher in the HSH-group the
acid-base parameters remained similar and within normal range. No adverse effects of the HSH
infusion were observed.
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9.1. Discussion
9.1. Fluid Load
        Cardiac surgery impacts fluid homeostasis more than other surgical interventions. Factors
responsible for increased fluid accumulation during cardiac surgery are the use of hemodilution,
hypothermia as well as a general inflammatory response caused by contact of blood with foreign
surfaces of the extracorporeal circuit and the surgical trauma. The adverse consequences of
extensive fluid loading and edema formation have during recent years gained increasing
attention. Even though the fluid load today is less than some decades ago, the amount of fluid
accumulated still has a clinical impact.
9.1.1. Hemodilution
Because of a number of unwanted adverse effects, heavy strain on blood banks, limited
resources and high cost, hemodilution was introduced by Panico and co-workers in 1960 (Panico
& Neptune 1960). Some amounts of blood, however, continued to be used as prime additive.
Lilleaasen studied extreme hemodilution where all blood prime was replaced with non-
sanguineous fluid. This resulted in a 70% reduction in the use of donor blood perioperatively
(Lilleaasen 1977). Today lactated or acetated Ringer’s solution is the main prime component in
most cardiac surgery centers.
              The volume of prime utilized is determined by the patient’s body surface area, initial
hematocrit and the “minimum safe volume”, which is the amount needed to fill the circuit and
maintain an adequate volume in the venous reservoir. Commonly the prime volume is in the
range of 1400-2200 ml, resulting in a hematocrit level of 25-30 % after initiation of CPB. The
lowest safe hematocrit value has been a matter of debate. Hematocrit as low as 14 % or lower
has been associated with an increased risk for mortality (Fang et al. 1997). Other investigators
report adverse effects at much higher hematocrit levels. DeFoe and co-workers studied 7000
patients. Hematocrit values of 23 % or below tended to increase the risk of mortality (DeFoe et
al. 2001). This is in line with an analysis of 5000 cardiac operations where hematocrit levels
below 22 % were associated with peri-operative higher incidence of vital organ dysfunction,
prolonged hospital stay, as well as increased short-and intermediate mortality (Habib et al.
2003). Reviews of almost 11.000 patients strengthened these findings, showing that from
hematocrit values of 29 %, the odds of stroke increased by 10 % for each 1 %-decrease of
hematocrit during CPB (Karkouti et al. 2005).
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               Mathew and co-workers found an associated risk of cerebral injury at low hematocrit
levels (hematocrit on CPB of 15-18 %) during CPB in their study of neurological outcome. This
study was interrupted due to higher incidence of adverse event in the low-hematocrit group,
including greater cognitive decline 6 weeks after surgery (Mathew et al. 2007).
In our animal studies the degree of hemodilution was similar in all groups, with a drop in
the Hct-values in the range of 26-28 %, except for the HES-group of study I, where Hct
decreased close to 40 % (table 1).
In our clinical study the reduction of hematocrit was in the range of 25 %, similar in both
groups, and well above any hematocrit level of concern.
Table 1.
CT-I Alb-I HES-I CT-II HSH-II CT-III HSD-III CT-IV HSH-IV
Hct
before
CPB
30.0(0.8) 30.0(0.8) 29.0(1.3) 30.0(2.5) 28.8(2.5) 29.5(2.8) 28.3(2.3) 30.1(1.2) 31.0(2.4)
Hct
after 60
minCPB
24.0(0.6) 23.0(0.9) 19.0(1.2) 24.4(2.1) 23.2(2.5) 23.1(2.4) 23.3(1.4) 23.0(2.3) 23.9(0.7)
Hct
after120
CPB
22.0(0.5) 22.0(1.0) 18.0(1.3) 21.8(1.8) 22.0(2.5) 20.7(0.9) 22.4(1.3) 23.7(3.0)* 23.7(0.9)*
  *tepid CPB
9.1.2. Hypothermia
Concomittant with hemodilution, - hypothermia was reintroduced to cardiac surgery in
1958 (Sealy et al. 1958). Moderate hypothermia (28-32 °C) decreases tissue oxygen
requirements by approximately 50% and provides organ protection against ischemic injury
(Bigelow et al.1954). A reduced tissue oxygen requirement implies the possibilities for lower
flow rates, which again might decrease shear stress of red cells and reduce hemolysis.
The blood viscosity changes inversely related to the changes of body temperature. The
higher blood viscosity under hypothermic conditions is counteracted by the effect of concomitant
hemodilution.
 During the last decade there has been a change in temperature strategy during CPB from
hypothermia (28°C) to a level of tepid temperature (34 °C) (Cook 1999). The change in
temperature level during CPB arose from studies of alternate cardioplegia techniques. Clinical
literature indicated advantages of warm continuous cardioplegia, and the investigation of
systemic normothermia followed (Lichtenstein et al. 1991). Normothermia allowed prompt
separation from CPB and cardiac output was found to improve. CK-MB release and the
incidence of myocardial infarction were less. 99 % of patients converted spontaneously to sinus
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rhythm, additionally these patients had much lower incidence of conduction abnormalities
postoperatively, and at long-term follow-up (Cook 1999).
               However, normothermic CPB patients were reported to require larger doses of
vasoconstrictors, greater fluid supplementation or higher CPB pump flows to maintain mean
arterial pressure (MAP) during CPB (Christakis et al. 1992; Cook 1999). Tepid/drifted
temperature (34 °C) seemed to have less disadvantages than both hypothermia and
normothermia, and was recommended for CPB (Arom et al. 1995; Cook 1999).
           Studies confirmed similar neurological outcome following tepid, “drifted” CPB (32-
34°C) compared with hypothermic CPB (about 28 °C) (Grigore et al. 2001). Most surgical
centres now use ”tepid” strategy for uncomplicated CABG surgery.
            Previous studies in our group have demonstrated increased fluid shifts from the
circulation to the interstitial space during hypothermia (Farstad et al. 2003; Farstad et al. 2004;
Heltne et al. 2000). In study I-III there is an increase in fluid extravasation in the control groups
after induction of hypothermia, confirming earlier findings from our group. This increase in fluid
extravasation could be partly counteracted by the specific interventions in the respective groups
(see table 2).
Table 2.
CT-I Alb-I HES-I CT-II HSH-II CT-III HSD-III
FER normothermia
30-60 (ml/kg/min)
0.15(0.1) 0.14(0.05) 0.33(0.10) 0.19(0.05) 0.15(0.03) 0.25(0.23) 0.01(0.04)
FER hypothermia
60-150 (ml/kg/min)
0.55(0.21) 0.12(0.09) 0.32(0.07) 0.51(0.10) 0.33(0.08) 0.57(0.14) 0.17(0.07)
By changing the temperature level from hypothermia in the direction of tepid temperature
in study IV we observed a reduction in fluid extravasation in both groups. Compared with
previous studies obtained from our group (Heltne et al. 2001) the fluid extravasation rate in CT-
group during tepid CPB was 25 % above the values observed during normothermic CPB. Using
HSH as prime additive the fluid leakage was significantly reduced compared to the CT-group
(Table 3).
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Table 3.
0-60 min CPB
FER(ml/kg/min) /Hct
60-120 min CPB
FER(ml/kg/min) / Hct
HSH-group-tepid     0.47 (0.20) / 23.9 (0.7)     0.17 (0.08) / 23.7 (0.9)
CT-group-tepid      1.00 (0.29) / 23.0 (2.3)     0.30 (0.08) / 23.7 (3.0)
Normotermia*      0.80 (0.2) / 24.6 (0.8)     0.10 (0.1) / 23.9 (0.9)
Hypothermia*      1.80 (0.2) / 19.1 (1.1)     1.1 (0.2) /  19.0 (1.0)
*(Heltne, et al. 2001)
9.1.3. Inflammation
              Cardiac surgery is associated with a systemic inflammatory reaction. The contact of
blood with surfaces of the CPB circuit, ischemia-reperfusion injury and release of endotoxins all
contributes to trigger the inflammatory response (Paparella et al. 2002). Also cardiac surgery
without the use of CPB contributes to activate inflammation (Gu et al. 1999). Tissue injury itself
caused by the surgical trauma is enough to trigger the response. The consequense of the
inflammatory response is leukocyte activation and a generalized impairment of the endothelial
barrier, resulting in increased microvascular permeability and diffuse capillary leakage. This
leads to leak of proteins, electrolytes and water from the intravascular compartment to the
interstitial space (Seghaye et al. 1996). The activation of inflammation involves several complex
pathways, too extensive to handle in this thesis. Only one will be mentioned briefly.
                  Surgery and CPB triggers a cascade of events, mediated by cytokines, including
TNF-	, IL-6 and IL-8. Levels of these pro-inflammatory cytokines have all been shown to
increase after CPB, and they are recognised as early mediators of organ injury (Teoh et al. 1995).
The pro-inflammatory cytokines might depress human myocardial contractile function, increase
systemic vascular permeability, and induce pulmonary vascular barrier dysfunction with
increased lung water content (Paparella et al. 2002).
               The anti-inflammatory cytokine IL-10 is an inhibitor of pro-inflammatory cytokines,
and might have a role in limiting the duration and extent of the acute inflammatory response. IL-
10 either directly inhibits the release of pro-inflammatory cytokines or indirectly exerts an anti-
inflammatory effect (Wan et al. 1997). Increased values might suggest a lower systemic
inflammatory reaction and a better hemodynamic performance (Giomarelli et al. 2003). Studies
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indicate that inflammatory cytokines and their suppressive cytokines increase but maintain their
balance during cardiac surgery (Kawamura et al. 1997). The balance among these cytokines may
be important in determining the level of the inflammatory response. If the balance tips over to an
overtly pro-inflammatory state the consequences may lead to myocardial damage.
                  Levels of TNF-	, IL-6, IL-8, and also IL-10 have peak values after surgery, 2-6 hours
(Teoh et al.1995; Kawamura et al.1997). Some studies indicate a peak of IL –10 before the pro-
inflammatory cytokines (Risnes et al. 2003; Kawamura et al. 1997). This might represent a
physiolgical mechanism to limit tissue damage and inflammation, and can indicate a delayed
capillary leakage. The process starts probably peroperativly, but the leakage continues for hours
after surgery. Local release of cytokines in the heart might be a contributing factor causing the
transient post-operative myocardial dysfunction (“stunning”) the first hours after CPB (Wan et
al.1997).
                  Hydroxyethyl starch seems to exert beneficial anti-inflammatory effects (Handrigan
et al. 2005; Boldt 2006; Gurfinkel et al. 2003), and to inhibit cytokines in experimental sepis
(Tian et al. 2005). The use of hypertonic saline has also been shown to reduce systemic and
pulmonary inflammatory responses (reduced levels of TNF-	 and IL-6) (Gurfinkel et al. 2003).
               In our clinical study we evaluated TNF-	, IL-6, IL-8 and IL-10 at baseline (1), after
onset of CPB (2), before weaning from CPB (3), after 2 hours (4), after 6 hours (5) and next
morning (6). TNF-	 remained essentially unchanged compared with the initial values. IL-6, IL-8,
IL-10 changed in similar patterns as described in other studies (Kawamura et al.1997; Risnes et
al. 2003) with significant increases in both groups at 6 hours, but with no between-group
differences. In this study we did not observe any anti-inflammatory effect of HSH.
Figure 5.
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9.2. Negative impact of fluid overload
         Fluid overloading with edema formation is a regular finding following on-pump cardiac
surgery. Tølløfsrud and co-workers found a fluid load of 5200 ml at the end of surgery when
acetated Ringer`s solution was used as prime (Tølløfsrud et al. 1995). This is in line with a
previous report by Utley on extensive fluid overloading following cardiac surgery with the use of
CPB (Utley JR & Stephens DB 1982). A mean accumulation of 800 ml/m2/hour during CPB was
determined. Hallowell and co-workers, found that almost 50 % of CABG patients had a fluid
balance greater than 5000 ml (Hallowell et al. 1978). Today most centres experience lower fluid
accumulation. 2000-2500 ml is often reported (Sirvinskas et al. 2007; Eising et al. 2001;
Kvalheim et al. 2009). Explanations for reduced fluid load today, is related to a change in
temperature strategy with reduced CPB time as well as smaller CPB-circuits.
In a study of patients admitted to surgical ICU significantly greater morbidity and length
of ICU stay was observed for patients who gained more than 10 % weight, indicating fluid
overload. Also mortality tended to increase as fluid overload increased (Lowell et al. 1990).
          An association between highly positive intraoperative fluid loading and postoperative
adverse outcome has been demonstrated in cardiac patients in recent years (Toraman et al.
2004). In a study of 1200 patients undergoing on-pump CABG, a fluid load of more than 500 ml
at the end of surgery was one of the predictors for increased transfusion needs and increased
length of hospital stay.
 Also following pulmonary surgery adverse outcome has been associated with heavy fluid
loading (Møller et al. 2002). In a regression analysis of elective patients undergoing
pneumonectomy, fluid balance exceeding 4000 ml was found to be the strongest risk factor for
post-operative pulmonary complications and in-hospital mortality (Møller et al. 2002).
Several authors have found fewer complications and earlier discharge by restrictive fluid
therapy in gastric patients (Lobo et al. 2006; Tambyraja et al. 2004).
 In a randomized multicenter trial (Brandstrup et al. 2003) patients were allocated to a
restricted or a standard fluid regimen during and after gastrointestinal surgery. Complications,
including anastomotic leakage, infections and transfusion needs were reduced in the restricted
fluid regimen group. Impeded tissue healing due to general edema may be one of the possible
explanations.
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9.2.1. Heart
             Myocardial edema has been reported to impair both systolic and diastolic function
(Mehlhorn et al. 2001). One study demonstrated a decrease in cardiac output by 40% for a given
preload when myocardial water content was increased by 3.5% (Laine & Allen 1991). Several
mechanisms may account for the reduction in cardiac performance. Tissue edema accumulates in
the interstitial spaces, thus increasing chamber stiffness and compromises the hearts ability to
contract efficiently. An increase in interstitial volume and pressure may also displace collagen
fibers, which might impact negatively on heart function (Laine & Allen 1991). Additionally,
myocardial edema will increase the diffusion distance for oxygen to the myocytes, resulting in
ischemia (Ziegler & Goresky 1971).
In our studies I-III, we observed significantly reduced water content in the heart tissue of
the study groups receiving colloides compared to the control groups. In study IV we used tepid
temperature, and the fluid leakage was less than that obtained in hypothermic studies (I-III).
                In the clinical study (V), a more favourable fluid balance was observed in the HSH-
group that was aproximatly 30 % below the values of the CT-group. The reduction, about 75%,
was most pronounced during the first 6-postoperative hours. Concomittant with this observation
CI (normalized values) was significantly higher in the HSH-group compared with CT-group.
Similar observations from previous studies confirms an association of reduced fluid load and
improved cardiac function (Oliveira et al. 1995; Tølløfsrud & Noddeland 1998; Schroth et al.
2006; Sirvinskas et al. 2007).
9.2.2. Lungs
            In a review of more than 8000 patients undergoing major surgery, Arieff found that the
overall incidence of postoperative pulmonary edema was 7.6 %, being fatal in 11.9 % of the
cases (Arieff 1999).
Edema might compromise both pulmonary gas exchange and tissue oxygenation leading
to decreased pulmonary function. In a study of healthy volunteers receiving 40 ml/kg of Ringer`s
solution, Holte and co-workers found a decreased pulmonary function for 8 hours and a
significant weight gain after 24 hours (Holte et al. 2003). Boldt and co-workers found that an
increase in extravascular lung water was accompanied by deterioration of pulmonary gas
exchange (Boldt et al. 1986). In study I, we found a significant increase in water content in the
lungs in the CT-group compared to a group of non-CPB animals. This fluid accumulation was
not found in the albumin and HES group. Preservation of COP seemed to prohibit the increase in
water accumulation in the lungs. In study II, we observed a significant reduction in total tissue
water in the lungs of the animals in the HSH-group compared to the animals of the CT-group.
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These findings were not reproduced in study III and IV, where no significant differences were
found. In study IV shorter CPB time and changed temperature strategy might explain these
results.
In study V, the clinical study, we were unable to find a significant difference in EVLWI
in the two groups, but normalized values of ITBVI was significantly higher in CT-group, and
GEDVI was significantly larger in HSH-group. These results are in line with the presence of an
increased intravascular pulmonary blood volume. The implications of that can so far only be
speculated on.
PaO2/FiO2 ratio behaved similarily in the two study groups initially. After 6 h the
PaO2/FiO2 ratio tended to rise more rapidly in the HSH-group compared to the CT-group. The
lack of significance between these two groups might be related to the variability of the patients
within the respective groups. Preoperative lung-examination was not done in these patients, and
even though the patients were described as healthy when considering lung disease, a greater
variation might be expected with increasing age (Gunnarsson et al. 1996).
9.2.3. Brain
            Cerebral injury is a frequent and feared complication after cardiac surgery.
Manifestations might vary from severe stroke resulting in death, paralysis /paresis to temporary
cognitive dysfunction. Mechanisms of cerebral injury from cardiac surgery might be caused by
air, by emboli, by peri-operative anemia or by hypoperfusion related to loss of cerebral
autoregulation (Hogue et al. 2008). Increased ICP and cerebral edema may worsen this ischemia.
By reducing ICP and brain water, improved cerebral perfusion pressure may be obtained.
              The use of HES in the prime-solution during coronary artery bypass was associated with
significant positive effects on informative-cognitive tests when compared to Ringer’s solution
(Iriz et al. 2005). The infusion of hypertonic saline/dextran in pigs before and after hypothermic
circulatory arrest was found to lower ICP and to significantly improve neurologic recovery in the
HSD –group (Kaakinen et al. 2006). McDaniel and co-workers added hypertonic saline/dextran
in the prime in an animal study, and observed stable ICP values and reduced cerebellar water
content in the animals (McDaniel et al. 1994). This is in line with our findings. In study II and III
we observed an increased ICP in the CT-group, whereas the ICP in the HSD- and HSH-groups
remained stable.
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9.3. Effects of colloid additives during CPB
          Hemodilution with crystalloid additives causes a reduction in COP. Approaches to reduce
this fall in COP could have a positive effect on outcomes after cardiac surgery. In animal studies
colloid hemodilution has been found to prevent the development of myocardial edema which
occurred with crystalloid hemodilution (Laks et al. 1977). Also pulmonary edema is found to be
reduced by colloid hemodilution (Eising et al. 2001). This is in line with our observations. In
study I we maintained COP by using colloides in the prime, and the fluid overload was
significantly reduced. We observed reduced tissue water in the hearts of the animals receiving
colloid compared to the animals receiving crystalloid prime. In study II and III the colloides
were administrated as a peroperative infusion. In both studies we observed more stable COP
values and reduction in fluid extravasation. As a result we observed a reduction of total tissue
water content in the heart, lungs and intestinal organs compared to the control animals.
Table 4 presents the average extravasation rate from initiation of CPB till the end of the
experiments, which was 150 min in study I-III, and 120 min in study IV.
Table 4.
Total FER during CPB
Study group FER ml/kg/min Study group FER ml/kg/min
 CT-I 0.58 (0.14)  Alb-I 0.13 (0.10)
 HES-I 0.20 (0.08)
 CT-II 0.66 (0.17)  HSH-I 0.39 (0.03)
 CT-III 0.78 (0.17)  HSD-II 0.41 (0.06)
*CT-IV 0.66 (0.18) *HSH-IV 0.31 (0.08)
 *tepid CPB
In study I fluid addition to the reservoir as well as blood replacements were isooncotic.
Consequently COP was maintained throughout the study, and might explain the low FER values
in study I.
9.3.1. Albumin
         In study I the CPB circuit was primed with Albumin 4 %, and when needed, albumin was
added to the reservoir. The cold-induced fluid leakage, as previously reported (Farstad et al.
2004; Heltne et al. 2000), was significantly reduced in the presence of albumin. Similar findings
were reported from a meta-analysis involving more than 1300 patients (Russell et al. 2004)
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where albumin favourably influenced COP and fluid balance. Marelli and co-workers
concluded on the other hand that there was no advantage adding albumin in the prime (Marelli et
al. 1989). Himpe reports in a meta-analysis including almost 1000 patients of a more favourably
fluid balance when colloids were added to the priming solution. Albumin was, however, not
associated with better outcome than other colloides in this review (Himpe 2003).
              In a retrospective study (Sedrakyan et al. 2003) of 20.000 patients undergoing cardiac
surgery through 1997 and 1998 albumin appeared to be associated with lower incidence of
mortality. Albumin was however, compared with all non-protein colloides, including dextrans,
gelantines and first generations of starch, and no separation of under-groups was done.
             A Cochran meta-analysis in 1998 suggested a worse outcome for patients given albumin
in ICU (Cochran 1998). In the SAFE study (Finfer et al. 2004), which was a prospective study
including 7000 intensive care  patients, no advantages of albumin as a plasma substitute was
observed and the worsended outcome as proposed the Cochran meta-analysis could not be
confirmed. Whether it is worth the price or not, is a still matter of debate.
9.3.2. Hydroxyethyl starch (HES)
              HES is the most often used colloid in Europe (Schortgen et al. 2004). A variety of
different solutions exist, which differ greatly in their pharmacological properties.
              Postoperative bleeding is a common complication of cardiac surgery, and it is estimated
that 50 % of cases undergoing re-operation because of bleeding results from multifactorial
coagulopathy (Paparella et al. 2004). It is of great importance that fluids added during and after
CPB do not worsen bleeding.
            Hydroxyethyl starches can interfere with normal hemostasis at different levels and an
impact on coagulation might occur (Kozek-Langenecker 2005).These findings are mostly based
on the use of first-generation starch-preparations with a molecular weight of 450 kD or higher,
and a high degree of molar substitution. The negative effect of HES on coagulation and bleeding
can probably be avoided by use of low- molar-weight, low-degree substitution HES in
recommended amounts ( Boldt 2009a; Thyes et al. 2006; Kozek-Langenecker 2005).
            Starch with lower Mw (130-200) and lower molar substitution (0.5 or less) have
significantly less impact on coagulation (Entholzner et al. 2000; Treib et al. 1996). Not only
weight and molar substitution but also the administered volume, have an influence on
coagulation (Thyes et al. 2006). Nevertheless, some studies demonstrate no adverse effects after
administration of larger volumes to multitrauma or orthopedic patients (Shatney et al. 1983;
Vogt et al. 1996). Also in cardiac surgery, low weight, low molar HES (130/0.40) at larger doses
has been found to be safe with regard to hemostasis (Boldt et al. 2009; Kasper et al. 2003).
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              A large meta-analysis reports increased blood loss in CPB patients exposed to HES
(Wilkes et al. 2001). This meta-analysis compared studies from the previous 20 years, - where
both HES 200 kD and HES 450 kD were used. There was no subgroup analysis, neither
according to molar substitution nor volume of transfusion.
             In study I-IV the effect on coagulation was not measured, as the animals were killed
after CPB and on-pump values are of limited interest. In study V, the effect on coagulation was
evaluated by the amount of bleeding from the chest drains, transfusions needs, as well as the
direct impact on the TEG-values. The TEG values were within normal range in both groups,
although a significant difference between the groups could indicate that HSH impaired
coagulation slightly. Coagulation index postoperatively was in HSH-group –1.3 (1.9) and in CT-
group -0.10 (1.7) (P = 0.024). Despite differences in TEG values, blood loss and transfusion
needs were similiar in the two groups.
          Others have experienced similiar observation; HES (200/0.5 or 130/0.4) solutions can
induce an impairment in fibrin formation and clot seen in TEG values, although no clinical
impacts concerning chest tube drainage and transfusion needs were observed (Schramko et al.
2009; Kuitunen et al. 2004).
              Renal dysfunction after cardiac surgery is in the range of 5 % (Antunes et al. 2004;
Boldt et al. 2003) and the causes  are multifactorial, though usually attributed to the use of CPB.
A possible detrimental impact of HES on kidney function has become an objection to use HES.
In a multicenter study of patients with severe sepsis higher frequency of acute renal
failure in the HES group than in the gelantin group was observed (Schortgen et al. 2001).
However, in this study HES 200/0.62 at doses of 31ml/kg were used. Additionally the study was
followed by criticism since serum creatinine was higher in the HES-group at baseline. In a study
of patients undergoing CABG, the use of HES was associated with a modest impairment in renal
function (Winkelmayer et al. 2003).In this study HES 670/0.75 was used.
Several studies show no negative effects on kidney function by use of HES; a large
observational study of 3147 critically ill intensive-care patients did not show higher incidence of
acute renal dysfunction in HES-treated patients compared to other plasma substitutes (Sakr et al.
2007). The use of HES 200/05 at doses of 15 ml/kg/day over five days to patients at ICU
including septic and trauma patients was also without negative effects on renal function (Boldt
2009b). By using the latest generations low weight (Mw< 200 kD), low molar substitution (MS
< 0.5), kidney function is not affected, suggesting no negative effects even in patients with
significantly altered kidney function (Boldt et al. 2007).
             Adverse renal effects were not evaluted in the experimental studies (I-IV). In study V,
however, we followed serum-creatinine levels during day 1, 2 and 3. No increases in the
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creatinine levels were found. We observed significantly higher diuresis the first 24-h in the
HSH-group compared to the CT-group.
9.3.3. Dextran
             Dextrans have well documented plasma expanding effects, and was the first colloid
combined in solution with hypertonic saline (Kramer 2003). Because of dextrans anticoagulant
effects they have shown to be effective in preventing postoperative venous thrombosis and
pulmonary embolism (Coats & Heron 2004). This effect might however be difficult to control in
the cardiac surgery patient, and combined with potential allergic reactions, a decrease in use is
seen. Dextrans do not longer play a role in cardiac surgery (Van der Linden & Ickx 2006;
Kreimeier & Peter 1998; Schumacher 2009).
             In study III we used the same protocol as in study II, which gave us an opportunity to
compare HSD and HSH with regard to their effect on fluid extravasation. No significant
between-groups values were observed. Total FER was more or less identical in the two groups,
0.39 (0.03) ml/kg/min in HSH group, and 0.41(0.06) ml/kg/min in HSD-group (table 4).
Fig.6.
9.3.4. Combination fluids
          The main use of combination fluids has been as small volume resuscitation in emergency
situations. There is no study demonstrating obvious adverse effects of hypertonic saline when
used in recommended amounts.
               An increased plasma chloride concentration could produce metabolic acidose that might
compromise cardiac function or cause arrhythmia. In a study from Vassar concerning potential
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risk associated with infusion of hypertonic saline in resuscitation situations a non-significant
correlation between pH and chloride concentration was found (Vassar et al. 1990). This is in line
with our findings. Although serum-chloride increased significantly, acid-base parameters
remained within normal ranges with no between-group differences.
            Austria was one of the first countries to approve hypertonic saline/ colloidal solutions,
and the patient material for registration of adverse drug reactions (ADR) is large. A review of a
10-year period concluded that ADR after use of HSH/HSD was low, and these solutions couldt
be considered relatively safe (Schimetta et al. 2002).
           Considerably elevated serum sodium levels have been reported after use of HSD/HSH in
cardiac surgery. Levels of 166 mmol/l has been seen by use of bolus administration of 3-4 ml/kg
of HSD (Oliveira et al.1995), however, with no neurological symptoms observed. In study II-V
serum sodium increased significantly, but remained at or below 150 mmol/l and no adverse
effects were seen.
Experience with use of HSH/HSD is mostly obtained from treatment of severe hypovolemia and
shock, and recommended doses have been 4 ml/kg. Also studies dealing with administration of
HSD/HSH in cardiac surgery reports of doses reaching 4.5 ml/kg at most (Tølløfsrud et al.
1998).
9.4. Administration forms
           Administration of hyperosmolar and/or colloidal additives has been given before and after
CPB, as well as an additive to the priming solution.
         Bueno and co-workers infused HSD as a bolus before valve surgery (Bueno et al. 2004).
Hemodynamic and respiratory function improved, peak values were obtainded shortly after
administration. Altough the effect declined postoperatively, the cardiorespiratory function were
better in the HSD-group compared to the control-group. Similiar findings were observed in a
group of Jehovaha`s witness (Oliveira et al.1995). Hemodynamic parameters improved shortly
after administration. In this study the effects on on hemodynamic were short-lived. In both
studies the fluid balance was favourable with the use of HSD.
                Eising and co-workers used HES in the prime, and observed improved CI and reduced
EVLW in the HES-group compared to a group with only crystalloid solution in the prime (Eising
et al. 2001). The improved hemodynamic and respiratory effects did not have peak values, but
seemed to gradually improve postoperatively. A significantly reduced fluid load was observed in
the HES-group.
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         Tølløfsrud and co-workers administered a bolus of HSD immediately after cardiac
surgery (Tølløfsrud & Noddeland 1998). They observed improved cardiac output, with peak
values shortly after administration. Fluid balance was lower in the HSD-group compared to the
control-group. Similiar findings were observed when HSH was administered as a bolus infusion
after arrival at the ICU (Sirvinskas et al. 2007). Positive impacts on hemodynamic parameters
were observed, also here peak values obtained shortly after infusion. Improved fluid balance in
the HSH-group compared to the control-group was found.
           Bolus administration of HSH has also been used after pediatric cardiac surgery (Schroth
et al. 2006). They observed improved CI, reduced SVRI, as well as reduced ELWI. Also in this
study group peak values were obtained shortly after administration of HSH.
           In our clinical practice we have used HSD or HSH as an infusion of 1ml/kg/h during 4
hours during resuscitation of victims with accidental hyopthermia. We observed lower fluid
needs and more stable hemodynamic variables during rewarming compared with treatment
protocols using crystalloid solution alone. In study V we used this administration form, 1ml/kg/h
HSH during 4 hours, starting preoperatively. We observed still increasing CI values 6 hours
postoperatively, and belive this administration form might be of benefit during the first
vulnerable hours postoperatively.
          Both the experimental studies and the clinical study confirm the effect of reduced fluid
load. Weather a slow peroperative infusion is favourable compared to a bolus infusion
conserning amount of fluid overload is uncertain.
 Administration of HSH as a bolus, given within minutes, might under given
circumstances induce post-infusion hypervolemic left heart failure and/or pulmonary edema, as
Prien and co-workers observed as transient findings after bolus infusion of HSH in CABG
patients (Prien et al. 1993). A review of hypertonic solutions in the operating room concludes
with benificial hemodynamic effects, and suggests that the rate of infusion should be slow
(Azoubel et al. 2008).To our knowledge there is no former study where HSH/HSD have been
administrated as a slow peroperative infusion during cardiac surgery. We observed that this
administration form caused a reduction in the total fluid load and an improvement of cardiac
performance in the early post-operative period.
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9.5. Future aspects
          The focus in fluid treatment for cardiac surgery should be to prohibit fluid loading, not to
replace losses. Numerous studies conserning negative impact of fluid overload exisist. Also the
adverse effects of high degree hemodilution are described. High-risk patients are an increasing
population in cardiac surgery, and these patients are vulnerable to the negative impacts of
hemodilution as well as fluid overload. The most obvious strategies to counteract these effects of
CPB are changes in the fluid additives and/or a reduction in the prime volume.
          The ideal fluid additive during and after cardiac surgery does still not exist. Controversy
consering crystalloid-colloid as well as colloid-colloid is still exisisting. The latest generation of
HES gives promising results, though further investigations are needed.
           By using a small volume of HSH as a slow infusion, we obtained favourable results
observing CABG patients with no co-morbidity, although these patients usually recover fast
anyway. We belive high-risk patients will have even more benefit of reduced fluid loading. Their
tolerance for hypervolemia is lower and the incidence for hemodynamic instability first hours
postoperatively is greater. A clinical study including high-risk patients is planned and has to be
performed.
Mini-bypass circuits are gaining increasing popularity. The reduced prime volume and
the antegrad priming of these circuits results in redused hemodilution, and lowered transcapillary
fluid leakage. Different priming alternatives in these mini-systems could contribute to even more
sophisticated fluid treatments protocols in the future.
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10. Conclusion
Based on the results from these studies we conclude;
• Maintainance of COP with an iso-oncotic prime during CPB reduces the cold-induced fluid
leakage
• A small infusion, 1ml/kg/h, of hyperosmolar/colloidal solution during CPB reduces FER and
NFB in pigs
• The infusions of HSH/HSD contributed to maintenance of ICP during hypothermic CPB,
while an increase of ICP was observed in the control group
• An additon of 4 ml/kg hyperosmolar/colloid solution in the prime reduced transcapillary
fluid leakage and NFB during tepid CPB
• Initiation of CPB caused highest FER values, this was significantly reduced by using
hyperosmolar/colloid in prime
• A small infusion, 1ml/kg/h during 4 h of hyperosmolar/colloid solution to elective CABG
patients reduced NFB and improved cardiac function
•  By using small volumes of HSD/HSH as a slow infusion during CPB we obtained
significantly less fluid load and organ edema. No adverse effects neither in the animals
studies, nor in the clinical study were observed.
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